TFF2 and systemic sclerosis: Although there is currently no direct evidence linking SP gene mutations to sarcoidosis, myositis-associated ILD, anti-synthetase syndrome-associated ILD, or SSc-ILD, their potential role in these conditions represents a promising avenue for future research.